Skip to main content
. 2022 Nov 3;12(11):1629. doi: 10.3390/biom12111629

Figure 2.

Figure 2

Illustrative diagram summarizing different pharmaceutical modalities for the management of neovascular age-related macular degeneration and their mechanisms of action.